Loading Chart...

Latest Trading on TSX

$3.52
4.61%
(-0.17)
Open 3.72
Previous Close 3.69
Today's Range
3.41 3.72
52 Week Range
3.41 13.86
Volume 20.61K
Avg. Volume (Weekly) 18.76K
Bid 3.48
Ask 3.55
Market Cap 29.71K
EPS -1.33
Shares Outstanding 8.05K
YTD High 8.20
Updated March 18, 2020

InMed Pharmaceuticals

InMed Pharmaceuticals ("InMed") was founded in 2014 and is based in Vancouver, British Columbia. The company has three primary areas of focus: 1) developing cannabinoid-based pharmaceuticals, 2) manufacturing cannabinoids through biosynthesis, 3) discovering treatments through bioinformatics.

No data to display.